Abstract
The efficacies of ketoconazole and two new imidazole preparations, Bay N7133 and Bay L9139, were compared in a rat model of experimental candida vaginitis. With a dosage regimen of 10 mg/kg by gavage for 5 days, the cure rate for ketoconazole was 96% as compared with rates of 23 and 29% for Bay N7133 and Bay L9139, respectively (P less than 0.001). Follow-up vaginal cultures at 30 days revealed a relapse in only 1 of 27 rats treated with ketoconazole. Our subsequent experiment in which ketoconazole regimens of 10 mg/kg were compared with Bay N7133 and Bay L9139 regimens of 25 mg/kg demonstrated cure rates of 100, 15, and 82% for the respective agents.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bisschop M. P., Merkus J. M., Scheygrond H., Van Cutsem J., van de Kuy A. Treatment of vaginal candidiasis with ketoconazole, a new, orally active, antimycotic. Eur J Obstet Gynecol Reprod Biol. 1979 Aug;9(4):253–259. doi: 10.1016/0028-2243(79)90065-0. [DOI] [PubMed] [Google Scholar]
- Fregoso-Dueñas F. Ketoconazole in vulvovaginal candidosis. Rev Infect Dis. 1980 Jul-Aug;2(4):620–622. doi: 10.1093/clinids/2.4.620. [DOI] [PubMed] [Google Scholar]
- McRipley R. J., Erhard P. J., Schwind R. A., Whitney R. R. Evaluation of vaginal antifungal formulations in vivo. Postgrad Med J. 1979 Sep;55(647):648–652. doi: 10.1136/pgmj.55.647.648. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Symoens J., Moens M., Dom J., Scheijgrond H., Dony J., Schuermans V., Legendre R., Finestine N. An evaluation of two years of clinical experience with ketoconazole. Rev Infect Dis. 1980 Jul-Aug;2(4):674–687. doi: 10.1093/clinids/2.4.674. [DOI] [PubMed] [Google Scholar]
- Thienpont D., Van Cutsem J., Borgers M. Ketoconazole in experimental candidosis. Rev Infect Dis. 1980 Jul-Aug;2(4):570–577. doi: 10.1093/clinids/2.4.570. [DOI] [PubMed] [Google Scholar]